| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 331.18M | 193.13M | 141.25M | 165.17M | 7.82M |
| Gross Profit | 218.30M | 112.18M | 38.68M | 57.25M | 2.51M |
| EBITDA | 246.61M | 129.38M | 46.94M | 85.06M | -1.69M |
| Net Income | 199.65M | 91.17M | 10.87M | 25.40M | -2.51M |
Balance Sheet | |||||
| Total Assets | 406.34M | 279.07M | 259.11M | 223.25M | 263.22M |
| Cash, Cash Equivalents and Short-Term Investments | 137.50M | 12.04M | 10.39M | 6.69M | 1.62M |
| Total Debt | 2.59M | 8.07M | 14.35M | 43.20M | 91.56M |
| Total Liabilities | 27.03M | 77.82M | 146.92M | 136.47M | 188.05M |
| Stockholders Equity | 379.32M | 201.25M | 111.39M | 86.78M | 75.17M |
Cash Flow | |||||
| Free Cash Flow | 183.85M | 57.66M | 35.41M | 55.71M | -63.73M |
| Operating Cash Flow | 188.92M | 61.76M | 63.84M | 84.39M | -22.36M |
| Investing Cash Flow | -28.09M | -12.87M | -38.45M | -30.55M | -44.75M |
| Financing Cash Flow | -32.82M | -44.70M | -25.07M | -48.43M | 37.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
88 Outperform | C$999.86M | 4.23 | 65.00% | 2.78% | 92.67% | 207.16% | |
66 Neutral | C$934.48M | 11.75 | 28.92% | ― | 45.36% | -14.35% | |
66 Neutral | C$1.69B | 10.62 | 18.62% | ― | 34.05% | 80.47% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | C$620.70M | -26.89 | -6.57% | ― | -5.94% | -153.35% | |
47 Neutral | C$1.62B | -66.86 | -72.54% | ― | ― | -111.48% |